EGFR-TKI as neoadjuvant treatment in patients with NSCLC with EGFR sensitive mutation: A retrospective real-world analysis

被引：0
|
作者：
Liu, Sangtian
Liang, Wenhua
He, Jianxing
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou, Peoples R China
[2] Guangzhou Med Univ, Affiliated Hosp 1, Dept Thorac Oncol & Surg,Natl Ctr Resp Med, State Key Lab Resp Dis,Natl Clin Res Ctr Resp Dis, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8081
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Obesity has an impact on the efficacy of EGFR-TKI in NSCLC patients harbouring EGFR mutation: A real-world study
    Ding, Z-Y.
    Chen, Y-Y.
    Hong, Y.
    Tong, L-P.
    Li, Q.
    Lin, P-P.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [2] Retreatment with EGFR-TKI for 541 NSCLC Patients with EGFR Mutation
    Takahashi, K.
    Ito, K.
    Murotani, K.
    Asada, K.
    Okuno, M.
    Kimura, T.
    Kubo, A.
    Suda, T.
    Taniguchi, H.
    Hataji, O.
    Shindo, J.
    Kunii, E.
    Yoshida, T.
    Imaizumi, K.
    Hida, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S833 - S833
  • [3] Efficacy and Toxicity of EGFR-TKI in Frail NSCLC with EGFR Mutation: A Retrospective Analysis in a Single Institution
    Akazawa, Y.
    Yoshikawa, A.
    Hashimoto, K.
    Kanazu, M.
    Yano, Y.
    Yamaguchi, T.
    Mori, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1002 - S1002
  • [4] Time to EGFR-TKI Treatment for Patients with Advanced NSCLC and EGFR Activating Mutation in a Tertiary Cancer Center
    Le Guevelou, Jennifer
    Dugue, Audrey
    Richard, Nicolas
    Dubos, Catherine
    Do, Pascal
    Danhier, Serge
    Lerouge, Delphine
    Bonneau, Jessica
    Blanc, Cecile
    Gervais, Radj
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1229 - S1229
  • [5] Real world study of lung squamous cell carcinoma patients with EGFR mutation treated with EGFR-TKI
    Miao, L.
    Lin, G.
    Wu, Y.
    Chen, J.
    Ai, X.
    Yuan, M.
    Chen, R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S96 - S96
  • [6] Retrospective Analysis of Real-World Management of EGFR-Mutated Advanced NSCLC, After First-Line EGFR-TKI Treatment: US Treatment Patterns, Attrition, and Survival Data
    Jorge Nieva
    Karen L. Reckamp
    Danielle Potter
    Aliki Taylor
    Ping Sun
    [J]. Drugs - Real World Outcomes, 2022, 9 : 333 - 345
  • [7] Retrospective Analysis of Real-World Management of EGFR-Mutated Advanced NSCLC, After First-Line EGFR-TKI Treatment: US Treatment Patterns, Attrition, and Survival Data
    Nieva, Jorge
    Reckamp, Karen L.
    Potter, Danielle
    Taylor, Aliki
    Sun, Ping
    [J]. DRUGS-REAL WORLD OUTCOMES, 2022, 9 (03) : 333 - 345
  • [8] Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR-Mutated NSCLC
    Urbanska, Edyta M.
    Grauslund, Morten
    Koffeldt, Peter R.
    Truelsen, Sarah L. B.
    Loefgren, Johan O.
    Costa, Junia C.
    Melchior, Linea C.
    Sorensen, Jens B.
    Santoni-Rugiu, Eric
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [9] Different first line EGFR-TKI regimen and the clearance of EGFR sensitive mutation in acquired EGFR-TKI resistant lung adenocarcinoma patients
    Zhuang, W.
    Xu, C.
    Wang, W.
    Song, Z.
    Zhu, Y.
    Chen, R.
    Guan, Y.
    Yi, X.
    Fang, M.
    Chen, G.
    Lv, T.
    Song, Y.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [10] Real-world utilization of EGFR TKI therapies and treatment outcomes in patients with advanced EGFR-sensitizing mutation-positive NSCLC.
    Riely, Gregory J.
    Lovly, Christine Marie
    Messina, Carlo G. M.
    Bienert, Stefanie
    Alexander, Kimberly
    Pao, William
    Baxi, Shrujal
    Doebele, Robert Charles
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345